Skip to main content
Top
Published in: Indian Journal of Surgery 3/2012

01-06-2012 | Editorial

Sentinel Lymph Node Biopsy in Breast Cancer-Should It Be the Standard of Care in India?

Author: Chintamani

Published in: Indian Journal of Surgery | Issue 3/2012

Login to get access

Excerpt

Breast cancer is fast emerging as the most common cancer amongst women in India and most cancers are locally advanced at presentation. The delayed presentation of breast cancers has generally been blamed on the poor socio-economic standards and lower literacy rates in India. There is however another facet to it that is related to the awareness of health providers .In a study conducted by the author, the delays in diagnosis of breast cancer were more often due to providers rather than patients [1]. Considering the shear burden of the disease,delayed presentation and lack of facilities in most centres, it is not likely that the minimally invasive approach to axilla i.e. Sentinel Lymph Node Biopsy (SLNB) becomes the standard of care in this part of the world in the near future [14]. …
Literature
1.
go back to reference Chintamani, Tuteja A, Khandelwal R, Tandon M, Bamal R, Jain S, Narayan N, Srinivas S, Kumar Y (2011) Patient and provider delays in breast cancer patients attending a tertiary care centre: a prospective study. JRSM Short Rep 2(10):76, Epub 2011 Oct 10PubMedCrossRef Chintamani, Tuteja A, Khandelwal R, Tandon M, Bamal R, Jain S, Narayan N, Srinivas S, Kumar Y (2011) Patient and provider delays in breast cancer patients attending a tertiary care centre: a prospective study. JRSM Short Rep 2(10):76, Epub 2011 Oct 10PubMedCrossRef
2.
go back to reference Saxena S, Rekhi B, Bansal A, Bagga A, Chintamani, Murthy NS (2005) Clinico-morphological patterns of breast cancer including family history in a New Delhi hospital, India–a cross-sectional study. World J Surg Oncol 3:67PubMedCrossRef Saxena S, Rekhi B, Bansal A, Bagga A, Chintamani, Murthy NS (2005) Clinico-morphological patterns of breast cancer including family history in a New Delhi hospital, India–a cross-sectional study. World J Surg Oncol 3:67PubMedCrossRef
3.
go back to reference Chakroborty A, Murthy NS, Chintamani, Bhatnagar D, Mohil RS, Sharma PC, Saxena S (2007) CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients. J Hum Genet 52(2):159–65CrossRef Chakroborty A, Murthy NS, Chintamani, Bhatnagar D, Mohil RS, Sharma PC, Saxena S (2007) CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients. J Hum Genet 52(2):159–65CrossRef
4.
go back to reference Chintamani, Tandon M, Mishra A, Agarwal U, Saxena S (2011) Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer–a prospective study. World J Surg Oncol 9:19PubMedCrossRef Chintamani, Tandon M, Mishra A, Agarwal U, Saxena S (2011) Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer–a prospective study. World J Surg Oncol 9:19PubMedCrossRef
5.
go back to reference Giuliano AE, Han SH (2011) Local and regional control in breast cancer: role of sentinel node biopsy. Adv Surg 45:101–116PubMedCrossRef Giuliano AE, Han SH (2011) Local and regional control in breast cancer: role of sentinel node biopsy. Adv Surg 45:101–116PubMedCrossRef
6.
go back to reference Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel lymph node resection compared with axillary-lymph node dissection in clinically node negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927–33PubMedCrossRef Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel lymph node resection compared with axillary-lymph node dissection in clinically node negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927–33PubMedCrossRef
7.
go back to reference Posther K, Mc Call LM, Blumencranz PW et al (2005) Sentinel node skills verification and surgeon performance data from a multicenter clinical trial for early stage breast cancer. Ann Surg 242:593–602PubMed Posther K, Mc Call LM, Blumencranz PW et al (2005) Sentinel node skills verification and surgeon performance data from a multicenter clinical trial for early stage breast cancer. Ann Surg 242:593–602PubMed
8.
go back to reference Goyal A, Newcombe R, Chhabra A et al (2006) Factors affecting failed localization and false negative rates of sentinel node biopsy in breast cancer-results of the ALMANAC-validation phase. Breast Cancer Res Treat 99:203–8PubMedCrossRef Goyal A, Newcombe R, Chhabra A et al (2006) Factors affecting failed localization and false negative rates of sentinel node biopsy in breast cancer-results of the ALMANAC-validation phase. Breast Cancer Res Treat 99:203–8PubMedCrossRef
9.
go back to reference Chintamani, Khandelwal R, Mittal A, Sai S, Tuteja A, Bhatnagar D, Saxena S (2007) Qualitative and quantitative dermatogluphic traits in patyients with breast cancer. BMC Cancer 7:44PubMedCrossRef Chintamani, Khandelwal R, Mittal A, Sai S, Tuteja A, Bhatnagar D, Saxena S (2007) Qualitative and quantitative dermatogluphic traits in patyients with breast cancer. BMC Cancer 7:44PubMedCrossRef
Metadata
Title
Sentinel Lymph Node Biopsy in Breast Cancer-Should It Be the Standard of Care in India?
Author
Chintamani
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Indian Journal of Surgery / Issue 3/2012
Print ISSN: 0972-2068
Electronic ISSN: 0973-9793
DOI
https://doi.org/10.1007/s12262-012-0588-3

Other articles of this Issue 3/2012

Indian Journal of Surgery 3/2012 Go to the issue

Review Article

Sils without Frills